Acumen Research and Consulting Ophthalmic Drugs Market | Page 7

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS 3.1. Capacity and Commercial Production Date of Global Ophthalmic Drugs Major Manufacturers in 2017 3.2. Manufacturing Plants Distribution of Global Ophthalmic Drugs Major Manufacturers in 2017 3.3. R&D Status and Technology Source of Global Ophthalmic Drugs Major Manufacturers in 2017 3.4. Raw Materials Sources Analysis of Global Ophthalmic Drugs Major Manufacturers in 2017 CHAPTER 4. Ophthalmic Drugs Market By Drug Class Outlook 4.1. Global Ophthalmic Drugs Revenue By Drug Class Outlook 4.2. Antiallergy 4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.3. Anti-Vascular Endothelial Growth Factor (Anti-Vegf) Agents 4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.4. Anti-inflammatory 4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.4.3. Nonsteroidal Drugs 4.4.4. Steroidal Drugs 4.5. Antiglaucoma 4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) 4.6. Others 4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million) 4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million) Would like to place an order or any question, please feel free to contact at [email protected] | [phone]